nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—ADRB1—periodontitis	0.403	0.513	CbGaD
Clenbuterol—TNF—periodontitis	0.383	0.487	CbGaD
Clenbuterol—NGF—submandibular gland—periodontitis	0.0652	0.887	CbGeAlD
Clenbuterol—ADRB3—connective tissue—periodontitis	0.00347	0.0471	CbGeAlD
Clenbuterol—Pirbuterol—ADRB1—periodontitis	0.00229	0.444	CrCbGaD
Clenbuterol—CYP1A1—mouth—periodontitis	0.00149	0.0203	CbGeAlD
Clenbuterol—Bupranolol—ADRB1—periodontitis	0.00148	0.286	CrCbGaD
Clenbuterol—ADRB1—connective tissue—periodontitis	0.00142	0.0193	CbGeAlD
Clenbuterol—Salbutamol—ADRB1—periodontitis	0.00139	0.269	CrCbGaD
Clenbuterol—CYP1A1—parotid gland—periodontitis	0.00104	0.0141	CbGeAlD
Clenbuterol—CYP1A1—epithelium—periodontitis	0.000868	0.0118	CbGeAlD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.000203	0.0015	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CD14—periodontitis	0.000198	0.00146	CbGpPWpGaD
Clenbuterol—TNF—IL27-mediated signaling events—IL6—periodontitis	0.000198	0.00146	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—IL1B—periodontitis	0.000197	0.00145	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL1A—periodontitis	0.000193	0.00142	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—IL6—periodontitis	0.000192	0.00141	CbGpPWpGaD
Clenbuterol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.000187	0.00138	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL4—periodontitis	0.000187	0.00138	CbGpPWpGaD
Clenbuterol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.000183	0.00135	CbGpPWpGaD
Clenbuterol—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—periodontitis	0.00018	0.00132	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—IFNG—periodontitis	0.00018	0.00132	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.000175	0.00129	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.000175	0.00129	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—TLR4—periodontitis	0.000174	0.00128	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCR2—periodontitis	0.000172	0.00127	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—CD14—periodontitis	0.00017	0.00125	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—CCL2—periodontitis	0.000168	0.00124	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—IL6—periodontitis	0.000167	0.00123	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	0.000166	0.00123	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—NTRK1—periodontitis	0.000165	0.00122	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—FGF2—periodontitis	0.000162	0.0012	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—CCL2—periodontitis	0.000162	0.00119	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TGFB1—periodontitis	0.000162	0.00119	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—GGT1—periodontitis	0.000162	0.00119	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—TNF—periodontitis	0.00016	0.00118	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—IL1B—periodontitis	0.00016	0.00118	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL3—periodontitis	0.000158	0.00117	CbGpPWpGaD
Clenbuterol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.000158	0.00116	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—FGF2—periodontitis	0.000157	0.00116	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.000156	0.00115	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL3—periodontitis	0.000156	0.00115	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IFNG—periodontitis	0.000156	0.00115	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL3—periodontitis	0.000155	0.00114	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TLR4—periodontitis	0.000155	0.00114	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL1A—periodontitis	0.000154	0.00114	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—PPARA—periodontitis	0.000154	0.00114	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL10—periodontitis	0.000153	0.00113	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.000153	0.00113	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TNF—periodontitis	0.000151	0.00112	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL3—periodontitis	0.000151	0.00111	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.000149	0.0011	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—IL6—periodontitis	0.000149	0.0011	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—NOS2—periodontitis	0.000147	0.00109	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—TGFB1—periodontitis	0.000146	0.00108	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—IL1A—periodontitis	0.000145	0.00107	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—CXCL8—periodontitis	0.000145	0.00107	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—TGFB1—periodontitis	0.000144	0.00106	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IFNG—periodontitis	0.000143	0.00105	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—IL1B—periodontitis	0.000139	0.00102	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—IL1B—periodontitis	0.000139	0.00102	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—PTGS2—periodontitis	0.000137	0.00101	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL3—periodontitis	0.000137	0.00101	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—TLR4—periodontitis	0.000136	0.001	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—IL6—periodontitis	0.000135	0.000993	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000134	0.000987	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCR2—periodontitis	0.000133	0.000985	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—ADRB1—periodontitis	0.000133	0.000981	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CCL2—periodontitis	0.000133	0.000979	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.000132	0.000971	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.000131	0.000966	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—IL6—periodontitis	0.000129	0.000955	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL1B—periodontitis	0.000127	0.000939	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	0.000126	0.000931	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.000121	0.000896	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.000119	0.000876	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.000118	0.000873	CbGpPWpGaD
Clenbuterol—CYP1A1—Arachidonic acid metabolism—PTGS2—periodontitis	0.000118	0.000871	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—CXCL8—periodontitis	0.000118	0.00087	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.000117	0.000866	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—IL6—periodontitis	0.000115	0.000851	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL1B—periodontitis	0.000113	0.000834	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VIP—periodontitis	0.000113	0.000833	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IFNG—periodontitis	0.000113	0.000832	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—periodontitis	0.00011	0.000812	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—VIP—periodontitis	0.000109	0.000803	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—PTGS2—periodontitis	0.000108	0.000798	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—TGFB1—periodontitis	0.000108	0.000795	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CXCL8—periodontitis	0.000105	0.000774	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.000104	0.000768	CbGpPWpGaD
Clenbuterol—NGF—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	0.000104	0.000765	CbGpPWpGaD
Clenbuterol—CYP1A2—Phase II conjugation—GGT1—periodontitis	0.000103	0.000759	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—periodontitis	0.000103	0.000757	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCR2—periodontitis	0.000102	0.000752	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.000102	0.000751	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.000101	0.000748	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL1B—periodontitis	0.000101	0.000742	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCR2—periodontitis	0.000101	0.000742	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCR2—periodontitis	9.97e-05	0.000735	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—VIP—periodontitis	9.88e-05	0.000729	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCR2—periodontitis	9.7e-05	0.000716	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—PPARA—periodontitis	9.66e-05	0.000713	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MMP9—periodontitis	9.49e-05	0.0007	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—periodontitis	9.45e-05	0.000697	CbGpPWpGaD
Clenbuterol—CYP1A1—Biological oxidations—GGT1—periodontitis	9.44e-05	0.000696	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—IL6—periodontitis	9.38e-05	0.000692	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—periodontitis	9.2e-05	0.000679	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	9.12e-05	0.000673	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL3—periodontitis	8.93e-05	0.000659	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL1B—periodontitis	8.83e-05	0.000651	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCR2—periodontitis	8.81e-05	0.00065	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL3—periodontitis	8.74e-05	0.000645	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	8.64e-05	0.000637	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—periodontitis	8.52e-05	0.000628	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	8.52e-05	0.000628	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—CXCL8—periodontitis	8.39e-05	0.000619	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	8.39e-05	0.000619	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	8.16e-05	0.000602	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL3—periodontitis	8.11e-05	0.000599	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL3—periodontitis	8.08e-05	0.000596	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL1B—periodontitis	8.05e-05	0.000594	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	8.04e-05	0.000593	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—IL6—periodontitis	7.97e-05	0.000588	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL3—periodontitis	7.94e-05	0.000586	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCR2—periodontitis	7.92e-05	0.000585	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCR2—periodontitis	7.82e-05	0.000577	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—TGFB1—periodontitis	7.82e-05	0.000577	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ADRB1—periodontitis	7.79e-05	0.000575	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCR2—periodontitis	7.75e-05	0.000572	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—ADRB1—periodontitis	7.72e-05	0.000569	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—IL1B—periodontitis	7.59e-05	0.00056	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CCR2—periodontitis	7.54e-05	0.000557	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	7.52e-05	0.000555	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—ADRB1—periodontitis	7.51e-05	0.000554	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	7.48e-05	0.000552	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—IL6—periodontitis	7.45e-05	0.00055	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	7.36e-05	0.000543	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—TGFB1—periodontitis	7.24e-05	0.000534	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—IL6—periodontitis	7.19e-05	0.000531	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCR2—periodontitis	6.85e-05	0.000505	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	6.83e-05	0.000504	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—ADRB1—periodontitis	6.82e-05	0.000503	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—IL6—periodontitis	6.62e-05	0.000488	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCL2—periodontitis	6.58e-05	0.000485	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—periodontitis	6.51e-05	0.000481	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—VIP—periodontitis	6.46e-05	0.000477	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NTRK1—periodontitis	6.38e-05	0.00047	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—VIP—periodontitis	6.32e-05	0.000466	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—GGT1—periodontitis	6.02e-05	0.000444	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP3—periodontitis	5.93e-05	0.000437	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—TGFB1—periodontitis	5.89e-05	0.000435	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—IL6—periodontitis	5.89e-05	0.000435	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—VIP—periodontitis	5.87e-05	0.000433	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VIP—periodontitis	5.84e-05	0.000431	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	5.81e-05	0.000429	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCR2—periodontitis	5.76e-05	0.000425	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—VIP—periodontitis	5.74e-05	0.000423	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCR2—periodontitis	5.63e-05	0.000416	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—IL6—periodontitis	5.45e-05	0.000402	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	5.43e-05	0.000401	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	5.43e-05	0.000401	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	5.32e-05	0.000392	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—PPARA—periodontitis	5.29e-05	0.00039	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCR2—periodontitis	5.23e-05	0.000386	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCR2—periodontitis	5.2e-05	0.000384	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CXCL8—periodontitis	5.2e-05	0.000384	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MMP3—periodontitis	5.19e-05	0.000383	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—IL6—periodontitis	5.17e-05	0.000381	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	5.13e-05	0.000378	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCR2—periodontitis	5.11e-05	0.000377	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	5.02e-05	0.00037	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC52A3—periodontitis	4.92e-05	0.000363	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MET—periodontitis	4.81e-05	0.000355	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL3—periodontitis	4.79e-05	0.000354	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—IL6—periodontitis	4.71e-05	0.000348	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL3—periodontitis	4.69e-05	0.000346	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CCR2—periodontitis	4.48e-05	0.00033	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CCR2—periodontitis	4.38e-05	0.000323	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—ADRB1—periodontitis	4.36e-05	0.000322	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCR2—periodontitis	4.07e-05	0.0003	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	4.05e-05	0.000299	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCR2—periodontitis	4.05e-05	0.000299	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADRB1—periodontitis	4.03e-05	0.000297	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP2—periodontitis	4.02e-05	0.000296	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCR2—periodontitis	3.98e-05	0.000293	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	3.97e-05	0.000293	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—ADRB1—periodontitis	3.96e-05	0.000292	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL2—periodontitis	3.9e-05	0.000288	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL2—periodontitis	3.85e-05	0.000284	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL2—periodontitis	3.82e-05	0.000282	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—FGF2—periodontitis	3.81e-05	0.000281	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.62e-05	0.000267	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—FGF2—periodontitis	3.48e-05	0.000257	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VIP—periodontitis	3.47e-05	0.000256	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VIP—periodontitis	3.39e-05	0.00025	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL2—periodontitis	3.38e-05	0.000249	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NTRK1—periodontitis	3.3e-05	0.000243	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC52A3—periodontitis	3.14e-05	0.000232	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCR2—periodontitis	3.09e-05	0.000228	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CXCL8—periodontitis	3.09e-05	0.000228	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MMP3—periodontitis	3.08e-05	0.000227	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP3—periodontitis	3.07e-05	0.000226	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CXCL8—periodontitis	3.05e-05	0.000225	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCR2—periodontitis	3.02e-05	0.000223	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CXCL8—periodontitis	3.02e-05	0.000223	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—periodontitis	3.02e-05	0.000223	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MMP3—periodontitis	3.01e-05	0.000222	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—CXCL8—periodontitis	2.94e-05	0.000217	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ACP5—periodontitis	2.9e-05	0.000214	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—periodontitis	2.76e-05	0.000203	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—periodontitis	2.67e-05	0.000197	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.59e-05	0.000191	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—periodontitis	2.49e-05	0.000184	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR2—periodontitis	2.4e-05	0.000177	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR2—periodontitis	2.35e-05	0.000173	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADRB1—periodontitis	2.34e-05	0.000173	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.31e-05	0.00017	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—periodontitis	2.27e-05	0.000168	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL2—periodontitis	2e-05	0.000148	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL2—periodontitis	1.99e-05	0.000147	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL2—periodontitis	1.96e-05	0.000145	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NTRK1—periodontitis	1.96e-05	0.000144	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NTRK1—periodontitis	1.92e-05	0.000141	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—periodontitis	1.87e-05	0.000138	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ACP5—periodontitis	1.85e-05	0.000136	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP3—periodontitis	1.82e-05	0.000134	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—FGF2—periodontitis	1.8e-05	0.000133	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP3—periodontitis	1.78e-05	0.000131	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—periodontitis	1.74e-05	0.000129	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—periodontitis	1.71e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—periodontitis	1.71e-05	0.000126	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.69e-05	0.000124	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.65e-05	0.000122	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GGT1—periodontitis	1.61e-05	0.000119	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—periodontitis	1.58e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—periodontitis	1.58e-05	0.000116	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—periodontitis	1.55e-05	0.000114	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—periodontitis	1.5e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—periodontitis	1.43e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL2—periodontitis	1.18e-05	8.73e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—periodontitis	1.18e-05	8.67e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL2—periodontitis	1.16e-05	8.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARA—periodontitis	1.16e-05	8.52e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.08e-05	7.93e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGF2—periodontitis	1.07e-05	7.89e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGF2—periodontitis	1.05e-05	7.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GGT1—periodontitis	1.03e-05	7.59e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—periodontitis	9.36e-06	6.9e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—periodontitis	9.15e-06	6.75e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—periodontitis	8.9e-06	6.57e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—periodontitis	8.86e-06	6.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—periodontitis	8.7e-06	6.42e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—periodontitis	8.46e-06	6.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—periodontitis	8.28e-06	6.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—periodontitis	7.51e-06	5.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARA—periodontitis	7.36e-06	5.43e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—periodontitis	6.98e-06	5.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—periodontitis	6.82e-06	5.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—periodontitis	5.26e-06	3.88e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—periodontitis	5.14e-06	3.79e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—periodontitis	4.79e-06	3.53e-05	CbGpPWpGaD
